Syntegra Private Wealth Group LLC Sells 336 Shares of Procter & Gamble Company (The) $PG

Syntegra Private Wealth Group LLC lessened its position in Procter & Gamble Company (The) (NYSE:PG) by 3.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,717 shares of the company’s stock after selling 336 shares during the period. Syntegra Private Wealth Group LLC’s holdings in Procter & Gamble were worth $1,389,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Kingstone Capital Partners Texas LLC increased its stake in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Northern Trust Corp boosted its holdings in Procter & Gamble by 0.8% in the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after acquiring an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. raised its holdings in Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG opened at $151.98 on Tuesday. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The stock has a market cap of $355.72 billion, a P/E ratio of 23.35, a P/E/G ratio of 4.02 and a beta of 0.36. The business’s 50 day moving average price is $154.86 and its 200-day moving average price is $158.59. Procter & Gamble Company has a 52 week low of $146.96 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The firm’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio is 64.82%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon R. Moeller sold 11,684 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. The trade was a 3.52% decrease in their position. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 in the last 90 days. Insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PG. Bank of America reduced their price target on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Raymond James Financial cut their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday. Evercore ISI reissued an “in-line” rating and issued a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, JPMorgan Chase & Co. reduced their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $171.68.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.